November 06, 2023
Due to Humana’s termination of our contract, as of February 14, 2024, we will no longer be considered an in-network provider. Humana Medicare Advantage patients can still receive treatment at NYOH until February 14, 2024. However, after this date,... Read more
August 24, 2023
NYOH recently welcomed Dr. Benjamin Laser to our medical staff, expanding our radiation oncology service offering. Our Practice President and Radiation Oncologist, Dr. Todd Doyle, emphasized, "Dr. Laser's integration into our committed NYOH team... Read more
March 01, 2022
We are pleased to announce that the American Society for Radiation Oncology (ASTRO) has accredited NYOH for Radiation Oncology through APEx - Accreditation Program for Excellence® for our Albany, Amsterdam and Clifton Park Cancer Centers. APEx is an... Read more
February 02, 2022
We are excited to announce that Dr. Charlene Ives has joined our team of oncologists and hematologists. Dr. Ives comes to us from Southwestern Vermont Regional Cancer Center, an affiliation of Dartmouth – Hitchcock. She completed her Fellowship in... Read more
December 15, 2021
Heidi E. Godoy, D.O., joined New York Oncology Hematology (NYOH) on December 1, 2021, expanding our service line offerings at our Albany Cancer Center to include gynecologic oncology and surgery. Dr. Godoy specializes in medically and surgically... Read more
June 24, 2021
We've concluded our 2021 monthly fireside chats. Stay tuned for our 2022 series. NYOH partnered with breast health and medical experts across the east coast to host monthly programming focused on breast health, cancer and survivorship. Dr. Maria... Read more
June 01, 2021
NYOH recently received designation by Highmark Blue Shield of Northeastern NY (NENY) as a Blue Distinction® Center for Cancer Care, which is part of the Blue Distinction Specialty Care program. By combining nationally consistent quality criteria... Read more
April 19, 2021
May 14 & 15, 2021 CME-Accredited Online LIVE Broadcast Conference ABOUT THE CONFERENCE New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH,... Read more
February 11, 2021
New York Oncology Hematology (NYOH) recently joined the MYLUNG consortium, a large-scale community-based research study to advance precision medicine options for non-small cell lung cancer (NSCLC) patients. NSCLC is the most common type of lung... Read more
February 01, 2021
Region’s Largest Cancer Provider Welcomes Well-Renowned Radiation Oncologist to Lead the Practice New York Oncology Hematology (NYOH) recently announced that its board of directors elected Dr. Todd Doyle to serve as the next practice president. Dr.... Read more